Annual Report 2024

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2024 122 The United Laboratories International Holdings Limited Annual Report 2024 33. SHARE-BASED PAYMENT TRANSACTIONS (Continued) Share award scheme (Continued) Details of movement in the numbers of award shares and the respective weighted average grant date fair value are follow: 2024 Weighted As at Granted Vested Lapsed Cancelled As at average fair 1 January during during during during 31 December value per Grantees Date of grant Vesting period 2024 the year the year the year the year 2024 award shares HK$ Directors Tsoi Hoi Shan 13 November 2023 13 November 2024 to 13 November 2026 575,100 – 191,700 – – 383,400 7.45 Leung Wing Hon 13 November 2023 13 November 2024 to 13 November 2026 401,100 – 133,700 – – 267,400 7.45 Choy Siu Chit 13 November 2023 13 November 2024 to 13 November 2026 268,800 – 89,600 – – 179,200 7.45 Fang Yu Ping 13 November 2023 13 November 2024 to 13 November 2026 186,900 – 62,300 – – 124,600 7.45 Zou Xian Hong 13 November 2023 13 November 2024 to 13 November 2026 186,900 – 62,300 – – 124,600 7.45 Zhu Su Yan 13 November 2023 13 November 2024 to 13 November 2026 186,900 – 62,300 – – 124,600 7.45 Other employees of the Group 13 November 2023 13 November 2024 to 13 November 2026 10,291,200 – 3,004,280 426,120 – 6,860,800 7.45 Total awarded shares granted 13 November 2023 13 November 2024 to 13 November 2026 12,096,900 – 3,606,180 426,120 – 8,064,600 7.45 Five highest paid individuals in aggregate 13 November 2023 13 November 2024 to 13 November 2026 1,618,800 – 539,600 – – 1,079,000 7.45